Pivot to Commercialize Cannabis Products in California Under New Regulations
03 janv. 2018 04h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) -- via NetworkNewsWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) is pleased to announce that its...
Pivot Initiates Development of Its First Cannabidiol Product with German Technology Partner
29 déc. 2017 08h05 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) -- via NetworkNewsWire - Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) is pleased to announce that it has...
Pivot Enters Into Standstill Agreement
27 déc. 2017 04h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 27, 2017 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) wishes to announce that it has...
Pivot To Enter Legal Cannabis Markets In U.S.
22 déc. 2017 09h25 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- via NetworkNewsWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), and its wholly-owned medical...
Pivot Pharma Signs Binding Letter of Intent to Acquire Cannabis Oil Infusion Technology for Use in Food and Beverage Products
20 déc. 2017 04h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), an emerging biopharmaceutical company, is pleased to...
Pivot Pharmaceuticals To Commence Trading on CSE
18 déc. 2017 05h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCQB:PVOTF) (“Pivot” or the “Company”), an emerging biopharmaceutical company, is pleased to announce that...
Pivot Pharmaceuticals Acquires BiPhasix™ Transdermal Drug Delivery Technology
12 sept. 2017 09h00 HE
|
Pivot Pharmaceuticals Inc.
Vancouver, British Columbia, Sept. 12, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), is pleased to announce that it has signed a Definitive Agreement...
Pivot Pharmaceuticals Files Application for Canadian Stock Exchange (CSE) Listing
12 juil. 2017 09h00 HE
|
Pivot Pharmaceuticals Inc.
BOSTON, MA and VANCOUVER, BC, July 12, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), a biotechnology company engaged in the development and...
Pivot Pharmaceuticals Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
30 mars 2017 09h00 HE
|
Pivot Pharmaceuticals Inc.
BOSTON, MA and VANCOUVER, BC, March 30, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), a biotechnology company engaged in the development and...
Pivot Appoints Dr. Pravin Chaturvedi, PhD to Chair Scientific Advisory Board
12 août 2015 09h00 HE
|
Pivot Pharmaceuticals Inc.
Vancouver, British Columbia, Aug. 12, 2015 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCPK: PVOTF) ("Pivot" or the "Company"), a biotechnology company engaged in the development and...